首页> 外文期刊>Journal of Clinical Medicine >Frailty and Sarcopenia Assessment upon Hospital Admission to Internal Medicine Predicts Length of Hospital Stay and Re-Admission: A Prospective Study of 980 Patients
【24h】

Frailty and Sarcopenia Assessment upon Hospital Admission to Internal Medicine Predicts Length of Hospital Stay and Re-Admission: A Prospective Study of 980 Patients

机译:医院入院的脆弱和康迟腺尼亚评估预测住院时间和重新入场的长度:对980名患者的前瞻性研究

获取原文
       

摘要

Background: Frailty and sarcopenia are associated with frequent hospitalizations and poor clinical outcomes in geriatric patients. Ascertaining this association for younger patients hospitalized in internal medicine departments could help better prognosticate patients in the realm of internal medicine. Methods: During a 1-year prospective study in an internal medicine department, we evaluated patients upon admission for sarcopenia and frailty. We used the FRAIL questionnaire, blood alanine-amino transferase (ALT) activity, and mid-arm muscle circumference (MAMC) measurements. Results: We recruited 980 consecutive patients upon hospital admission (median age 72 years (IQR 65–79); 56.8% males). According to the FRAIL questionnaire, 106 (10.8%) patients were robust, 368 (37.5%) pre-frail, and 506 (51.7%) were frail. The median ALT value was 19IU/L (IQR 14–28). The median MAMC value was 27.8 (IQR 25.7–30.2). Patients with low ALT activity level (17IU/L) were frailer according to their FRAIL score (3 (IQR 2–4) vs. 2 (IQR 1–3); p 0.001). Higher MAMC values were associated with higher ALT activity, both representing robustness. The rate of 30 days readmission in the whole cohort was 17.4%. Frail patients, according to the FRAIL score (FS), had a higher risk for 30 days readmission (for FS 2, HR = 1.99; 95CI = 1.29–3.08; p = 0.002). Frail patients, according to low ALT activity, also had a significantly higher risk for 30 days readmission (HR = 2.22; 95CI = 1.26–3.91; p = 0.006). After excluding patients whose length of stay (LOS) was ≥10 days, 252 (27.5%) stayed in-hospital for 4 days or longer. Frail patients according to FS had a higher risk for LOS ≥4 days (for FS 2, HR = 1.87; 95CI = 1.39–2.52; p 0.001). Frail patients, according to low ALT activity, were also at higher risk for LOS ≥4 days (HR = 1.87; 95CI = 1.39–2.52; p 0.001). MAMC values were not correlated with patients’ LOS or risk for re-admission. Conclusion: Frailty and sarcopenia upon admission to internal medicine departments are associated with longer hospitalization and increased risk for re-admission.
机译:背景:Freailty和Sarcopenia与频繁的住院和老年患者的临床结果有关。确定这一协会为内科部门住院的年轻患者可以帮助更好的预后在内科领域的患者。方法:在内科部门的一年前瞻性研究中,我们评估了患者的患者,患有SARCOPENIA和FRAILTY。我们使用了Flail调查表,血液丙氨酸 - 氨基转移酶(ALT)活性和中臂肌圆周(MAMC)测量。结果:我们在医院入院时招聘了980名患者(中位年龄72岁(IQR 65-79); 56.8%的男性)。根据勒布调查问卷,106名(10.8%)患者稳健,368(37.5%)预体积,506(51.7%)是脆弱的。中位数alt值是19iu / l(IQR 14-28)。中位数MAMC值为27.8(IQR 25.7-30.2)。患有较低的ALT活性水平(<17IU / L)的患者是根据其虚弱评分(3(IQR 2-4)与2(IQR 1-3); P <0.001)。较高的MAMC值与较高的ALT活动相关,两者都代表稳健性。整个队列中30天的速度为17.4%。脆弱患者,根据FRAIR评分(FS),风险较高30天即将入院(FS> 2,HR = 1.99; 95CI = 1.29-3.08; P = 0.002)。根据低ALT活性的脆弱患者,30天即将入院的风险显着更高(HR = 2.22; 95CI = 1.26-3.91; P = 0.006)。在排除患者长度(LOS)≥10天后的患者后,252(27.5%)留在医院4天或更长时间。根据FS的脆弱患者患者≥4天的风险较高(FS> 2,HR = 1.87; 95CI = 1.39-2.52; P <0.001)。根据低ALT活性的脆弱患者也处于LOS≥4天的风险较高(HR = 1.87; 95CI = 1.39-2.52; P <0.001)。 MAMC值与患者的洛杉矶或重新入场的风险无关。结论:在进入内科部门的入院期间有关的脆弱和康迟尼亚症与再入场的风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号